A research focusing on the change of small RNA molecules in MDD indicated that the differentially expressed miRNAs in the brains of MDD patients could downregulate the expression of erb-b2 receptor tyrosine kinase 4, and influence phenylalanine and tyrosine metabolism (60). The gene discussed is ERBB4; the disease is major depressive disorder.